openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Geron Corporation (NASDAQ: GERN) over potential Wrongdoing

An investigation on behalf of current long term investors in Geron Corporation (NASDAQ: GERN) shares.

An investigation on behalf of current long term investors in Geron Corporation (NASDAQ: GERN) shares.

An investigation was announced for long-term investors in shares of Geron Corporation (NASDAQ: GERN) concerning potential breaches of fiduciary duties by certain directors of Geron Corporation.

Investors who are current long term investors in Geron Corporation (NASDAQ: GERN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: GERN stocks follows a lawsuit filed against Geron Corporation over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: GERN stocks, concerns whether certain Geron Corporation directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that, the defendants provided investors with material information concerning defendants' expectations for the launch and growth potential of Rytelo (imetelstat), and that the defendants' statements included, among other things, confidence in Geron's ability to capitalize on the purportedly significant unmet need for the drug and to execute on its commercial plan to target first-line ESA ineligible patients, while continually minimizing the risks associated with the burden of the weekly monitoring requirement for Rytelo and the impacts of seasonality and existing competition on the drug's sales.

Those who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Geron Corporation (NASDAQ: GERN) over potential Wrongdoing here

News-ID: 4029297 • Views:

More Releases from Shareholders Foundation, Inc.

Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potential Wrongdoing
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for long term investors in
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ: FTNT)
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on October 07, 2025
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR)
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Geron

Geron Corporation (NASDAQ: GERN) Investor Alert: Deadline in Lawsuit on May 12, …
A deadline is coming up on May 12, 2025 in the lawsuit filed for certain investors of Geron Corporation (NASDAQ: GERN) over alleged securities laws violations by Geron Corporation. Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and there are strict and short deadlines running. Deadline: May 12, 2025. Geron Corporation (NASDAQ: GERN) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According
Lawsuit filed for Investors who lost money with shares of Geron Corporation (NAS …
An investor, who purchased shares of Geron Corporation (NASDAQ: GERN), filed a lawsuit over alleged violations of Federal Securities Laws by Geron Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and for certain investors are short and strict deadlines running. Deadline: May 12, 2025. NASDAQ: GERN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Stem Cell Therapy Market is Going to Boom | Geron Corp., Pluristem Therapeutics, …
Advance Market Analytics published a new research publication on "Stem Cell Therapy Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Stem Cell Therapy market was mainly driven by the increasing R&D spending across the world. Get inside Scoop of the
Investigation for Long-Term Investors in shares of Geron Corporation (NASDAQ: GE …
An investigation was announced for current long-term investors in shares of Geron Corporation (NASDAQ: GERN) concerning potential breaches of fiduciary duties by certain directors and officers of Geron Corporation. Investors who are current long term investors in Geron Corporation (NASDAQ: GERN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Deadline in Lawsuit for Investors in shares of Geron Corporation (NASDAQ: GERN) …
The Shareholders Foundation announced that a deadline is coming up on March 23, 2020 in the lawsuit filed for certain investors of Geron Corporation (NASDAQ: GERN) over alleged securities laws violations by Geron Corporation. Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and there are strict and short deadlines running. Deadline: March 23, 2020. NASDAQ: GERN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Lawsuit filed for Investors in shares of Geron Corporation (NASDAQ: GERN)
An investor, who purchased shares of Geron Corporation (NASDAQ: GERN), filed a lawsuit over alleged violations of Federal Securities Laws by Geron Corporation. Investors who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and for certain investors are short and strict deadlines running. Deadline: March 23, 2020. NASDAQ: GERN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Geron Corporation was developing imetelstat in partnership